Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tranexamic acid for reduction of preoperative hidden blood loss in elderly intertrochanteric femur fracture
ChiCTR1800017761Phase 4Not yet recruiting
- Sponsor
- Chongqing General Hospital
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tranexamic acid in intertrochanteric fracture (2 arms), sponsored by Chongqing General Hospital. Primary endpoints: Hemoglobin, Hematocrit and 3 more. Planned start Sep 2018; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on ChiCTR1800017761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017761.